SLC25 family with energy metabolism and immunity in malignant tumors

Author:

Zhang Guiqian1234,Wang Ning1,Ma Shixun235,Wei Zhenhong54,Tao Pengxian12365,Cai Hui1235ORCID

Affiliation:

1. First Clinical Medical College , Gansu University of Chinese Medicine , Lanzhou , China

2. Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province , Gansu Provincial Hospital , Lanzhou , China

3. General Surgery Clinical Medical Center, Gansu Provincial Hospital , Lanzhou , China

4. Cadre Ward of General Surgery Department , Gansu Provincial Hospital , Lanzhou , China

5. NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor , Gansu Provincial Hospital , Lanzhou , China

6. Institute of Clinical Medicine and Translational Medicine , Gansu Provincial People’s Hospital , Lanzhou , China

Abstract

Abstract Solute Carrier Family 25 (SLC25) is the largest family of mitochondrial membrane proteins in the human body, consisting of 53 members. Mitochondrial phosphate carriers (MPiC), cellular iron metabolism, voltage-dependent anion channels (VDAC), and oxidative phosphorylation in the SLC25 family play dominant roles in material transport, energy metabolism, etc. SLC25 family-related proteins are involved in the regulation of the progression of a variety of cancers, including colon, gastric, and lung cancers. In addition, the SLC25 family has been implicated in endoplasmic reticulum stress (ERS) and immunity. Since SLC25 family proteins are involved in cancer progression and are associated with endoplasmic reticulum stress and immunity, exploring inhibitors of SLC25 family-related proteins is essential. However, the exact mechanism of SLC25 family-related proteins involved in cancer, as well as potential targets and SLC25 inhibitors have not been reported in the literature. This article focuses on summarizing the relevance of the SLC25 family to cancer, ERS, and immunity. This review also provides a comprehensive overview of SLC25 family-related inhibitors.

Funder

Natural Science Foundation of Gansu Province

Gansu Provincial Youth Science and Technology Fund Program

National Health Commission Key Laboratory Master’s and Doctor’s Fund Programs

Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences

The 2021 Central-Guided Local Science and Technology Development Fund

Key talent project of Gansu Province of the Organization Department of Gansu Provincial Party Committee

Key project of science and technology innovation platform fund of Gansu Provincial People’s Hospital

Gansu Provincial People’s Hospital Excellent Master/PhD Student Incubation Program Project Fund

Postdoctoral Fund of Gansu Provincial People’s Hospital

Publisher

Walter de Gruyter GmbH

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3